$LXRX Update — Topline-data TOMORROW 8am ET / $0.70 SP biopharma with 82.61% ($235,796,000) institutional holding and potential to trigger major short-squeeze
$LXRX Update — Major topline-data TOMORROW 8am ET / $0.70 SP biopharma with 82.61% ($235,796,000) institutional holding and potential to trigger major short-squeeze
CATALYST TOMORROW: Lexicon Pharmaceuticals to Announce Topline Results from Phase 2b PROGRESS Study Evaluating Pilavapadin (LX9211) in Adults with Diabetic Peripheral Neuropathic Pain
$LXRX DD (Update) — $0.70 SP biopharma with 82.61% ($235,796,000) institutional holding and major upcoming data readout; potential to cause a major short-squeeze event
$LXRX DD — $0.70 SP biopharma with major upcoming catalyst causing potential short squeeze; 82.61% ($235,796,000) institutional holding and largest options volatility on NASDAQ (300%+IV-30)
LXRX- DD Report Feb 13, 2024
$LXRX DD Update — 24th February 2025: Huge institutional holding, short interest and hints at positive data readout by end-of-quarter
$LXRX DD (Update) — $0.70 SP biopharma with major impending data readout; potential to cause a major short-squeeze event (300%+iV-30), 83% institutional holding ($235,796,000)
🇹🇭🇪 🇱🇴🇺🇳🇬🇪 February 16, 2025
ConnectM Announces Explosive Growth in EV Solutions, Driven by OEM Partnerships and Surging Demand
$LXRX Update + News
Lexicon Pharmaceuticals DD — Awaiting major Phase 2b topline data by end of Q1 2025 (1-5 week-long play)
FBLG Archive
$FBLG DD: Small biopharma backed by BlackRock with possible upcoming catalysts Feb 11
BlackRock-backed ($3m+) biopharma $FBLG loading for potential 2x run with likely catalysts by 12 Feb
$FBLG News Date (Prediction), SEPA Update, Institutional Activity
🇹🇭🇪 🇱🇴🇺🇳🇬🇪 February 12, 2025
$MGOL is it dead or not yet???
$MGOL, a word of caution
🇹🇭🇪 🇱🇴🇺🇳🇬🇪 February 09, 2025
Discord Server - Early DD Releases
Montgolfier Update 6/2/25
First time - Thanks MGOL Guy!
$MGOL Risk Update & Warning
